CVS vs EQ · P/E 16, rev $402.07B vs rev $41.1M
CVS Health Corp (CVS) versus Equillium Inc (EQ) — a side-by-side from cached financials, not a winner call.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
Equillium Inc (EQ) is a biotechnology company listed on NASDAQ.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Latest reported EQ revenue for 2024-12-31 was $41.1M. Net income was -$8.1M. Revenue was up 13.9% from 2023-12-31 to 2024-12-31. EQ currently screens at market cap $189.0M.
CVS currently screens at market cap $86.20B and trailing P/E 16.3. EQ currently screens at market cap $189.0M.
Not investment advice. Open the CVS and EQ stock pages for the full models.
Not investment advice.